Ansell Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Ansell han disminuido a una tasa media anual de -6.3%, mientras que en la industria Medical Equipment los beneficios crecieron en un 8.3% anualmente. Los ingresos han ido creciendo a una tasa media de 0.9% al año. La rentabilidad financiera de Ansell es de 4.1%, y sus márgenes netos son de 4.7%.

Información clave

-6.3%

Tasa de crecimiento de los beneficios

-5.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	5.8%
Tasa de crecimiento de los ingresos	0.9%
Rentabilidad financiera	4.1%
Margen neto	4.7%
Próxima actualización de resultados	09 Feb 2025

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos

Cómo gana y gasta dinero Ansell. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

CHIA:ANN Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Jun 24	1,619	77	429
31 Mar 24	1,612	90	423
31 Dec 23	1,605	104	414
30 Sep 23	1,630	126	410
30 Jun 23	1,655	148	409
31 Mar 23	1,717	147	411
31 Dec 22	1,778	145	413
30 Sep 22	1,865	152	413
30 Jun 22	1,952	159	412
31 Mar 22	2,025	188	435
31 Dec 21	2,098	218	458
30 Sep 21	2,063	232	469
30 Jun 21	2,027	247	480
31 Mar 21	1,913	222	465
31 Dec 20	1,798	197	450
30 Sep 20	1,706	177	433
30 Jun 20	1,614	157	416
31 Mar 20	1,570	147	405
31 Dec 19	1,527	138	394
30 Sep 19	1,513	125	388
30 Jun 19	1,499	112	381
31 Mar 19	1,496	112	380
31 Dec 18	1,493	112	378
30 Sep 18	1,491	125	384
30 Jun 18	1,490	139	390
31 Mar 18	1,461	135	387
31 Dec 17	1,433	132	384
30 Sep 17	1,404	125	374
30 Jun 17	1,375	119	363
31 Dec 16	1,232	121	283
30 Sep 16	1,292	129	301
30 Jun 16	1,353	137	319
31 Mar 16	1,578	164	412
31 Dec 15	1,583	169	414
30 Sep 15	1,614	178	427
30 Jun 15	1,645	188	441
31 Mar 15	1,690	126	461
31 Dec 14	1,734	64	482
30 Sep 14	1,662	53	470
30 Jun 14	1,590	42	459
31 Mar 14	1,507	95	443
31 Dec 13	1,425	148	428

Ingresos de calidad: ANN tiene una única gran pérdida de $66.2M que afecta a sus resultados financieros de los últimos 12 meses de 30th June, 2024.

Margen de beneficios creciente: Los actuales márgenes de beneficio(4.7%) de ANN son inferiores a los del año pasado (9%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de ANN han disminuido en un 6.3% al año en los últimos 5 años.

Acelerando crecimiento: ANN ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: ANN tuvo un crecimiento negativo de los beneficios (-48.4%) durante el año pasado, lo que dificulta la comparación con la media de la industria Medical Equipment (18.7%).

Ansell Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2024 earnings released: EPS: US$0.59 (vs US$1.17 in FY 2023)

Ansell Limited to Report Fiscal Year 2025 Results on Aug 26, 2025

First half 2024 earnings released: EPS: US$0.15 (vs US$0.51 in 1H 2023)

Full year 2023 earnings released: EPS: US$1.18 (vs US$1.25 in FY 2022)

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Recent updates

Ansell Limited Announces Zubair Javeed Intention to Resign as Chief Financial Officer

Final dividend of US$0.22 announced

Ansell Limited Announces Final Dividend for the Year Ended June 30, 2024 , Payable on September 12, 2024

New minor risk - Profit margin trend

Full year 2024 earnings released: EPS: US$0.59 (vs US$1.17 in FY 2023)

Ansell Limited (ASX:ANN) completed the acquisition of Personal Protective Equipment business of Kimberly-Clark Corporation (NYSE:KMB).

Ansell Limited to Report Fiscal Year 2025 Results on Aug 26, 2025

Ansell Limited has filed a Follow-on Equity Offering in the amount of AUD 400.000001 million.

Ansell Limited has filed a Follow-on Equity Offering in the amount of AUD 400.000001 million.

First half dividend of US$0.17 announced

First half 2024 earnings released: EPS: US$0.15 (vs US$0.51 in 1H 2023)

Ansell Limited Declares Dividend for the Six Months Ended December 31, 2023, Payable on March 14, 2024

Ansell Limited Provides Earnings Guidance for the Year 2024

Ansell Limited Declares Final Dividend for Year Ended 30 June 2023, Payable on 7 September 2023

Full year 2023 earnings released: EPS: US$1.18 (vs US$1.25 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Ansell Limited Provides Earnings Guidance for the Full Year Ended 30 June 2023 and Fiscal Year 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Now 21% undervalued after recent price drop

Ansell Limited Announces Board Changes, Effective on 24 October 2023

First half 2023 earnings released: EPS: US$0.51 (vs US$0.61 in 1H 2022)

Now 24% undervalued after recent price drop

Ansell Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 9, 2023

Ansell Limited Announces Appointment of Debra Goodin as an Independent Nonexecutive Director

Non-Executive Director recently bought AU$130k worth of stock

Ansell Limited to Report First Half, 2023 Results on Feb 14, 2023

Full year 2022 earnings released: EPS: US$1.25 (vs US$1.92 in FY 2021)

Ansell Limited, Annual General Meeting, Oct 26, 2023

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Ansell Limited Announces Dividend for the Period of Six Months Ended December 31, 2021, Payable on March 09, 2022

Investor sentiment deteriorated over the past week

Ansell Limited Revises Earnings Guidance for the Fiscal Year 2022

High number of new directors

Ansell Limited Provides Earnings Guidance for the Fiscal Year 2022

Full year 2021 earnings released: EPS US$1.92 (vs US$1.22 in FY 2020)

New 90-day high: AU$39.25

First half 2021 earnings released: EPS US$0.83 (vs US$0.50 in 1H 2020)

Revenue misses expectations

Ansell Limited Revises Financial Guidance for the Fiscal Year 2021

Ansell Limited (ASX:ANN) acquired life science business from Primus Gloves Private Limited and SANREA Healthcare Products Pvt Limited.

Independent Non-Executive Director recently sold AU$260k worth of stock

New 90-day low: AU$35.58

MD, CEO & Executive Director recently sold AU$3.2m worth of stock

New 90-day high: AU$42.03

New 90-day high: AU$41.05

Independent Non-Executive Director recently bought AU$55k worth of stock

Independent Non-Executive Director recently bought AU$55k worth of stock

Full year earnings released - EPS AU$1.22

Ansell Limited to Report Fiscal Year 2021 Results on Aug 24, 2021

New 90-day high - AU$40.57

New 90-day high - AU$39.20

Ansell Limited (ASX:ANN) completed the acquisition 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS).

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado